News & Updates
Filter by Specialty:

Inhaled amikacin cuts VAP burden in mechanically ventilated patients
16 Jan 2024
byAudrey Abella
In critically ill patients who have been on invasive mechanical ventilation (IMV) for at least 3 days, a subsequent 3-day course of preventive inhaled amikacin reduced the burden of ventilator-associated pneumonia (VAP) during 28 days of follow-up, findings from the AMIKINHAL trial have shown.
Inhaled amikacin cuts VAP burden in mechanically ventilated patients
16 Jan 2024
mRNA boosters protect cancer patients against adverse COVID-19 outcomes
08 Jan 2024
byAudrey Abella
A prospective study from Singapore provides evidence of the clinical effectiveness of mRNA-based vaccines against COVID-19 in individuals with cancer.
mRNA boosters protect cancer patients against adverse COVID-19 outcomes
08 Jan 2024
Singapore faces high asthma burden
05 Jan 2024
byJairia Dela Cruz
Singapore is disproportionately burdened by asthma, with related hospitalizations and emergency department (ED) visits occurring twice as often as the average of other developed countries, according to a study.